Reach Us +44-1202-068036
COX-2 Inhibitor Prevents Esophageal Adenocarcinoma In Barrett?s Esophagus | 8123
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

COX-2 Inhibitor prevents esophageal adenocarcinoma in Barrett?s Esophagus

International Conference and Exhibition on Metabolomics & Systems Biology

Fadhil Alamran

ScientificTracks Abstracts: J Comput Sci Syst Biol

DOI: 10.4172/0974-7230.S1.02

Endometriosis is a gynecological disease characterized by the presence of endometrial tissue comprising the endometrium located outside the uterine cavity. It is often found at the peritoneum, ovary, or fallopian tube, and rarely at the pleura, lung, or brain. However, despite its prevalence, endometriosis is still poorly understood. The purposes of this study is to identify the differences in the protein expression between the endometriosis and non-endometriosis patients from the blood using the proteomics and metabolomics method in order to discover specific causable biomarker proteins and metabolites of endometriosis patients. In the profiling of the blood from women with or without endometriosis, 20 protein spots and 25 lipoidal hormones were found to be differentially expressed with changes in the density by two-fold or more with its down or up-regulation. Only 4 protein spots were found in the non-endometriosis patients. To confirm the possible involvement of these proteins and metabolites, we analyzed the change in these protein spots and metabolites from blood, classified by American Society for Reproductive Medicine (1997). In the classification system, the morphology of peritoneal and ovarian implants is categorized into four stages; minimal (stage 1), mild (stage 2), moderate (stage 3) and severe (stage 4). Among the candidate protein and metabolites, only the 4 protein spots and some lipoidal hormones decreased in stage 2, 3, and 4 compared to stage 1 of endometriosis. In the conclusion, this finding suggests possible involvement of these identified proteins in understanding the pathogenesis of endometriosis.
Dr. Hong-gu Lee has completed his Ph.D at the age of 33 years from Iwate University in Japan and research professor from Seoul National University. He has published more than 50 papers in SCI journals and 32 papers in domestic journals.
Leave Your Message 24x7